IPO Update - Claris Lifesciences Ltd (Revised) : SHAREKHAN

Claris Lifesciences Ltd
Price band (Revised): Rs 228 to Rs 235
Issue opens on: November 24, 2010 | Issue closes on (Revised): December 2, 2010
Issue opens on: November 24, 2010
Issue closes on (Revised): December 2 , 2010
Lot size: 22 shares and in multiples of 22 shares thereafter
Revised Price band: Rs228 - Rs235
Issue size: Rs 300 crore

Issue highlights (source: BRLM/RHP)

  • Claris Lifesciences Ltd (CLL), is one of the largest Indian pharmaceutical companies catering to the niche segment of sterile injectables.

  • CLL has presence across 76 countries and achieved approximately 1,100 product registrations worldwide with 332 pending approval.

  • CLL has been successful in garnering approvals from foreign regulatory authorities which include USFDA, MHRA (UK), TGA (Australia) and GCC FDCA.

  • The Key products of CLL such as propofol, iron sucrose, hydroxyl ethyl starch, ciprofloxacin and metronidazole have large markets worldwide with very little competition for CLL on these products due to the company's complex manufacturing process.

  • CLL believes it is the sole company in India that possesses the technology to produce unibag non-PVC infusion system. Thus, the company plans to leverage this expertise and competitive advantage by aggressively marketing these drugs and gain a strong foothold in the global markets.

  • Its business arrangement with pharmaceutical behemoth Pfizer Inc. with a view to expanding its business in the USA and the other regulated markets will significantly augment revenues and bottom line with higher product and facility approvals from the USFDA and other regulatory bodies.

  • Its shareholders includes renowned private equity player Carlyle PE, which invested Rs90.5 crore in it in March 2006 for a 13.9% stake.

  • Financial Performance: Total sales grew at a compounded annual growth rate (CAGR) of 29%, its earnings before interest, tax, depreciation and amortisation grew at a CAGR of 59% and its net profit increased at 65% over FY2005-09.


Post a Comment

All comments are moderated. Please post no spam

Disclaimer & Privacy Policies

(c) Mrs. Ruby Christy. This site and contents are owned by Mrs. Ruby Christy;
Use of this website and/or services offered by us indicates your acceptance of our Disclaimer& Privacy Policies.

Information and opinions provided on this website (www.investchips.com) has been independently obtained from sources believed to be reliable. However, such information may include inaccuracies, errors or omissions. Investchips.com and its affiliates, information providers or content providers and R.John Christy and his Family shall have no liability to you or third parties for the accuracy, completeness, timeliness or correct sequencing of information available on this website or feeds, or for any decision made or action taken by you in reliance upon such information, or for the delay or interruption of such information. Investchips.com,its affiliates, information providers ,content providers and R. John Christy and his Family shall have no liability for investment decisions or other actions taken or made by you based on the information provided on this website. Any action you choose to take in the markets is totally your own responsibility. Investchips.com and R. John Christy and his Family will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information. This information is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. Opinions expressed by R. John Christy are his own and not of his past, present and future employers.
The DoubleClick DART cookie is used by Google in the ads served on this websites displaying AdSense for content ads. When users visit this website and either view or click on an ad, a cookie may be dropped on that end user's browser.
  • Google, as a third party vendor, uses cookies to serve ads on this site.
  • Google's use of the DART cookie enables it to serve ads to your users based on their visit to this site and other sites on the Internet.
  • Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy.
  • www.investchips.com never collects any personal information of visitors.